Omnicell Investor Presentation Deck
© 2023 Omnicell, Inc.
Reconciliation of GAAP net income per share - diluted to non-GAAP net income per share - diluted:
Shares diluted GAAP
Shares diluted non-GAAP (b)
GAAP net income per share - diluted
Share-based compensation expense
Amortization of acquired intangibles
Acquisition accounting impact related to deferred revenues
Omnicell, Inc.
Reconciliation of GAAP to Non-GAAP
(Unaudited, in thousands, except per share data and percentage)
Non-GAAP dilutive shares impact from convertible note hedge transaction
(a)
Tax effect of the adjustments above
Non-GAAP net income per share - diluted
(a)
Acquisition-related expenses
Impairment and abandonment of operating lease right-of-use and other assets related to facilities
Ransomware-related expenses, net of insurance recoveries
Executives transition costs
Severance-related expenses
Amortization of debt issuance costs
Reconciliation of GAAP net income to non-GAAP EBITDA):
GAAP net income
Share-based compensation expense
Interest (income) and expense, net
(b)
(c)
Acquisition-related expenses
Impairment and abandonment of operating lease right-of-use and other assets related to facilities
Ransomware-related expenses, net of insurance recoveries
Executives transition costs
Severance-related expenses
Amortization of debt issuance costs
Provision for (benefit from) income taxes
Non-GAAP EBITDA
Non-GAAP EBITDA margin (non-GAAP EBITDA as a % of total non-GAAP revenues)
Depreciation and amortization expense
Acquisition accounting impact related to deferred revenues
(b)
$
$
$
$
Three Months Ended June 30,
2023
2022
45,472
45,472
0.08 $
0.31
0.17
15.7%
0.01
0.02
0.02
0.02
(0.06)
0.57
3,451 S
14,089
(4,410)
22,080
246
841
721
1,046
8,758
46,822
$
46,260
45,361
16.9%
0.20
0.38
0.19
0.01
0.01
0.07
0.03
0.02
(0.07)
0.84
9,069
17,213
(142)
21,893
302
263
3,340
1,374
1,041
1,705
56,058
Tax effects calculated for all adjustments except share-based compensation expense, using an estimated annual effective tax rate of 21% for both fiscal years 2023 and 2022.
For the three months ended June 30, 2022, non-GAAP diluted shares excluded approximately 0.9 million shares related to the impact of dilutive convertible senior notes for which the Company is
economically hedged through its anti-dilutive convertible note hedge transaction.
Defined as earnings before interest income and expense, taxes, depreciation, amortization, and share-based compensation, as well as excluding certain other non-GAAP adjustments.
24View entire presentation